Even an higher valuation than $132 million if a partner enters in a constructive deal that finance the diversified pipeline development. I am a bit concerned about the amended recruiting plan. Based on the past I would stay with the original plan. But they are the professionals and they know what the FDA demands.
Even an higher valuation than $132 million if a partner enters...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
